Utility Therapeutics Ltd. | Finanzwire

Basculer en Français

10184	Companies
209565	Keywords
139697	Articles
111103	Press releases

Headlines Articles Press releases Utility Therapeutics Ltd.

Home
Companies
Utility Therapeutics Ltd.

PRESS RELEASE

published on 01/17/2024 at 12:00, 2 years 2 months ago

UTILITY therapeutics Ltd. Announces Financing Led by the AMR Action Fund and FDA Acceptance of PIVYA New Drug Application with Priority Review
UTILITY therapeutics Ltd. announces a private financing led by the AMR Action Fund and the U.S. FDA's acceptance of its New Drug Application (NDA) for PIVYA, a European-approved antibiotic for the treatment of uncomplicated urinary tract infections (UTIs). PIVYA has received the FDA's qualified infectious disease product (QIDP) designation, providing an additional 5 years of market exclusivity upon approval. This new antibiotic offers a unique mechanism of action and aims to address the rising rates of antimicrobial resistance. For more information, visit www.utilitytherapeutics.com.

UTILITY Therapeutics PIVYA Urinary Tract Infections Antibiotic FDA Approval

Accesswire

Published on 04/09/2026 at 19:15, 1 hour 8 minutes ago

Murchison Minerals Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Published on 04/09/2026 at 16:00, 4 hours 23 minutes ago

Banff Half Marathon Completes 2025 Emissions Assessment, Supporting Climate Action with Karbon-X
Published on 04/09/2026 at 14:40, 5 hours 43 minutes ago

Silver X Delivers Production Growth During the First Quarter of 2026
Published on 04/09/2026 at 14:00, 6 hours 23 minutes ago

Orogen Royalties Announces Mineral Reserve and Resource Update on Producing Ermitaño Royalty
Published on 04/09/2026 at 13:30, 6 hours 53 minutes ago

Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate

View all ACCESSWIRE

EQS Group

Published on 04/09/2026 at 20:03, 20 minutes ago

Annual General Meeting approves all proposals
Published on 04/09/2026 at 18:15, 2 hours 8 minutes ago

REPLY: Launch of a share buyback program for a maximum number of 3,607,950 shares
Published on 04/09/2026 at 15:59, 4 hours 24 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 04/09/2026 at 15:57, 4 hours 26 minutes ago

Cairn Homes Plc: Holding(s) in Company
Published on 04/09/2026 at 15:40, 4 hours 43 minutes ago

Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

Les Echos

Published on 04/09/2026 at 18:35, 1 hour 48 minutes ago

Availability of proxy documents for the Combined General Meeting of April 30, 2026
Published on 04/09/2026 at 17:35, 2 hours 48 minutes ago

SUEZ - FY 2025
Published on 04/09/2026 at 15:57, 4 hours 26 minutes ago

Filing of CNP Assurances SA 2025 universal registration document and 2025 Solvency and Financial Condition Reports
Published on 04/09/2026 at 07:00, 13 hours 23 minutes ago

bioMérieux Unveils its BIOFIRE® SPOTFIRE® Molecular Testing Solution for the Pharmaceutical Industry, Redefining Rapid Mycoplasma Testing
Published on 04/08/2026 at 18:02, 1 day 2 hours ago

Publication of the 2025 Universal Registration Document

View all LES ECHOS COMFI WIRE